The FDA should create an expedited pathway for clinical tests targeting emerging drug threats, write Dr. Shravani Durbhakula and Jeremy Kourvelas.
Enzymes are the molecular tools of life. They accelerate chemical reactions and are able to distinguish very precisely ...
The latest data on the midterm elections, presidential approval and more. 59 new polls added conducted Oct. 28 to Nov. 1. 74 new polls added 19 new polls added 44 new polls added 42 new polls added ...
Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug and medical device regulation, and what we’re reading from around the web. This week, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results